![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Stanford University |
---|---|
Information provided by: | Stanford University |
ClinicalTrials.gov Identifier: | NCT00352326 |
For children who depend on devices to communicate, the rate of communication is a primary determinant of success. For children with motor impairments, the rate of communication may be limited by inability to contact buttons or cells rapidly or accurately. It is therefore essential to know how to adjust the device interface in order to maximize each child’s rate of communication. The optimal rate of communication is determined by the Channel Capacity, which is the maximum value of the Information Rate for all possible keyboard button or cell layouts for the communication device. We construct a mathematical model for the information rate based on the relationship between movement time and the number of buttons per screen, the size of the buttons, and the length of a sequence of buttons that must be pressed to communicate each word in the vocabulary. We measure the parameters of the model using a custom-programmed touch-screen interface.
Condition | Intervention | Phase |
---|---|---|
Cerebral Palsy |
Device: reprogramming assisted communication device interface |
Phase I Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
Official Title: | OPTIMIZING ASSISTED COMMUNICATION DEVICES FOR CHILDREN WITH MOTOR IMPAIRMENTS USING A MODEL OF INFORMATION RATE AND CHANNEL CAPACITY |
Ages Eligible for Study: | 6 Years to 21 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United States, California | |
Stanford University | |
Stanford, California, United States, 94305 |
Principal Investigator: | Terence Sanger, MD Phd | Stanford University |
Study ID Numbers: | FITTS PILOT |
Study First Received: | July 12, 2006 |
Last Updated: | July 12, 2006 |
ClinicalTrials.gov Identifier: | NCT00352326 |
Health Authority: | United States: Food and Drug Administration |
Paralysis Cerebral Palsy Brain Damage, Chronic |
Central Nervous System Diseases Brain Diseases Brain Injuries |
Nervous System Diseases |